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ABSTRACT
Background: Liver cirrhosis (LC) is a chronic disease characterized by damage of liver parenchyme with 
wide fibrosis and nodules formation. One of LC complications is cirrhotic cardiomyopathy (CC). CC is diagnosed 
when there are more than one of the following signs: diastolic dysfunction (DD), systolic dysfunction (SD), 
enlargement of the cardiac chamber, electrophysiology dysfunction, and increasing of natriuretic peptide such 
as N terminal–pro brain natriuretic peptide (NT-proBNP). The aim of this study was to determine the correlation 
between degree of liver cirrhosis and increasing of the NT-proBNP.
Method: Cross sectional analytic study was performed with 72 LC patients from May 2014 to May 2015 in 
Sanglah General Hospital, Denpasar. Degree of liver cirrhosis was determined by child turcotte pugh (CTP) 
criteria and NT-proBNP was examined by electro chemiluminescence immunoassay (ECLIA) method. LC patients 
with other disorders which can cause the increase of NT-proBNP were excluded. Statistical analysis used was 
Spearman’s correlation test. 
Results: Of 72 LC patients, 79.2% were male. Patients with CTP A were 9 (12,5%), CTP B 19 (26,4%) and 
CTP C 44 (61,19%). Median of NT-proBNP in CTP A was 112 pg/mL, CTP B 130 pg/mL, and CTP C 315 pg/
mL. There was a strong possitive correlation between degree of liver cirrhosis and NT-proBNP (r = 0.686; p 
= 0.000). In this study, there was also significant comparison between NT-proBNP and CTP A,B, and C (p = 
0,000) and there was no significant relation between NT-proBNP and those cofounding variables (p > 0.05).
Conclusion: there was a strong possitive correlation between degree of LC and NT-proBNP.
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ABSTRAK
Latar belakang: Sirosis hati (SH) adalah penyakit hati menahun yang ditandai oleh kerusakan parenkim 
hati dan fibrosis luas disertai pembentukan nodul. Salah satu komplikasi dari SH adalah kardiomiopati sirosis 
(KS). Kriteria diagnosis KS adalah ditemukan lebih dari satu kelainan berupa disfungsi diastolik atau disfungsi 
sistolik, perubahan struktur ruang jantung, gangguan elektrofisiologi, dan peningkatan peptida natriuretik seperti 
N terminal–pro brain natriuretic peptide (NT-proBNP). Penelitian ini bertujuan untuk mengetahui korelasi 
antara derajat sirosis hati dengan peningkatan NT-proBNP pada pasien sirosis hati.
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Metode: Penelitian ini merupakan studi potong lintang analitik terhadap 72 penderita SH dari Mei 2014 
hingga Mei 2015 di Rumah Sakit Umum Sanglah, Denpasar. Derajat sirosis hati ditentukan dengan child turcotte 
pugh (CTP), dan NT-proBNP diperiksa dengan metode electro chemiluminescence immunoassay (ECLIA). 
Beberapa kondisi yang mempengaruhi peningkatan NT-proBNP dieksklusi. Korelasi derajat SH dan NT-proBNP 
dianalisis dengan uji Spearman.
Hasil: Dari 72 sampel, 79.2% laki-laki. 9 (12,5%) orang dengan CTP A, 19 (26,4%) orang CTP B, dan 44 
(61,1%) orang CTP C. Median nilai NT-proBNP pada CTP A adalah 112 pg/mL, CTP B 130 pg/mL, dan pada 
CTP C 315 pg/mL. Terdapat korelasi positif kuat yang bermakna antara derajat penyakit SH dengan peningkatan 
NT-proBNP (r = 0,686 dan p = 0,000). Pada studi ini juga didapatkan perbedaan bermakna NT-proBNP antara 
kelompok CTP A, B, dan C. Pada studi ini, peningkatan NT-proBNP tidak dipengaruhi oleh variabel perancu 
(p > 0.05).
Simpulan: Terdapat korelasi positif kuat yang bermakna antara derajat SH dengan peningkatan NT-proBNP.
Kata kunci: sirosis hati, child turcotte pugh , NT-proBNP
INTRODUCTION
Liver cirrhosis (LC) is a chronic disease characterized 
by damage of liver parenchyme with wide fibrosis 
and nodules formation. One of LC complications 
is cirrhotic cardiomyopathy (CC). The pathogenic 
processes of LC lead to change in cardiac structures 
and function. The clinical manifestations of CC such as 
diastolic dysfunction (DD), systolic dysfunction (SD), 
enlargement of the cardiac chamber, electrophysiology 
dysfunction, and increasing of natriuretic peptide 
(NT-proBNP).1 Cardiac manifestation in cirrhotic 
patients remains a particular concern in clinical practice 
since cardiac dysfunction was associated with worse 
prognosis and higher risk for death.
N terminal–pro brain natriuretic peptide is an 
active form of BNP, composed of 76 amino acids, 
produced by the cardiac ventricles which is involved 
in the regulation of fluid volume and cardiovascular 
homeostasis. Elevation in plasma NT-proBNP reflect 
fluid overload. Plasma NT-proBNP is increased in a 
number of disease states including congestive heart 
failure, chronic renal failure, chronic obstructive 
pulmonary diasese, diabetes mellitus, hyperthyroid, 
anemia, sepsis, and liver cirrhosis. In LC patients, 
elevation of NT-proBNP as a mark of cardiac 
dysfunction related to liver cirrhosis.2,3
Child turcotte pugh (CTP) scoring system is the 
most commonly used clinical method for classifying 
LC. Score of the CTP reflects the damage of liver 
parenchyms. The damage of liver parenchyms 
related to blunt receptor of cardiac beta adrenergic, 
increase the ammount of endocanabinoid, nitrit oxide, 
carbon monoxide, and the stiffness of myocardium. 
Those conditions will cause diastolic, systolic, and 
electrophysiology dysfunction.4,5 The relationship 
between the severity of liver disease and NT-proBNP 
as a mark of cardiac dysfunction is controversial. 
Although some studies have shown no relationship 
between degree of LC and NT-proBNP, other 
studies have shown a relationship between those 
conditions.6,7,8,9 Aim of this study was to determine 
the correlation between degree of liver cirrhosis and 
increasing of the NT-proBNP in Sanglah General 
Hospital.
METHOD
Cross sectional analytic study was conducted in 72 
patients consecutively in Sanglah General Hospital, 
Denpasar, between May 2014 and May 2015. The 
inclusion criteria were adult liver cirrhotic patients. 
Other disorders such as hypertension, congestive 
heart failure, coronary heart disease, atrial fibrilation, 
valvular heart disease, chronic obstructive pulmonary 
disease, stage III-V chronic kidney diasease , diabetes 
mellitus, hyperthyroid, sepsis, septic shock, and history 
of angiotensin converting enzyme (ACE) inhibitor, 
angiotensin receptor blockers (ARB), calcium 
antagonist, thrombocyte anti aggregation, digitalis, 
nitrate, and statin more than 1 week were excluded.
Degree of liver cirrhosis was determined by CTP 
criteria and NT-proBNP was examined by electro 
chemiluminescence immunoassay (ECLIA) method. 
Correlation between degree of liver cirrhosis and NT-
proBNP was analyzed by using Spearman’s correlation 
test. The comparison of NT-proBNP level between 
CTP groups was analyzed by Kruskall-Wallis test and 
continued with post hoc Mann-Whitney test to compare 
the increase of NT-proBNP in each CTP groups. 
Multivariate analysis of the cofounding variables using 
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Chi-square comparison test. Data which had been 
included in the research form, was processed by SPSS 
program version 21. The study was commenced after 
having an ethical approval by the Ethical Committee at 
Faculty of Medicine, University of Udayana.
RESULTS
Between May 2014 and May 2015, 72 LC patients 
were conducted. 79,2% were male. Mean age of 
patients was 47,4 ± 7,1 years. Bassed on degree of liver 
cirrhosis, the comparison between CTP A, B, and C 
were 9 (12,5%) : 19 (26,4%) : 44 (61,19%). Most of 
the patients came to the hospital in severe condition 
(CTP C). Median of NT-proBNP in CTP A was 112 
(5-180) pg/mL, CTP B 130 (11,7-860) pg/mL, and 
CTP C 315 (86-1980) pg/mL. The lowest level of NT-
proBNP was 5 pg/mL found in CTP A and the highest 
one was 1980 pg/mL in CTP C. Anemia and other 
conditions such as diuretics and beta blockers usage as 
a cofounding variables in this trial were found mostly 
in CTP C group. 
Descriptive study such as frequency, mean, standard 
deviation, median, minimal and maximal data were 
used to describe the profile of LC patients in Sanglah 
Hospital. In this study, the number of liver cirrhosis 
patient in Sanglah Hospital was still high and most 
of them were male and came to the hospital in severe 
condition (CTP C). The highest median level of NT-
proBNP was found in CTP C group and the cofounding 
variable such as anemia, diuretics, and beta blockers 
usage were found mostly in CTP C group. 
There was a strong possitive correlation between 
degree of liver cirrhosis and NT-pro BNP (r = 0.686; 
p = 0.000). Spearman’s correlation test was performed 
to evaluate the correlation between degree of liver 
cirrhosis and NT-proBNP. 
Figure 1. Correlation between degree of liver cirrhosis and 
NT-proBNP
Table 1. Baseline characteristics of the patients
Variables Totaln (%)
CTP A
n (%)
CTP B
n (%)
CTP C
n (%)
Patients (n) 72 9 (12.5%) 19 (26.4%) 44 (61.1%)
Sex
Male 57 (79.2 %) 8 (88.9%) 12 (63.2%) 37 (84.1%)
Female 15 (20.8%) 1 (11.1%) 7 (36.8%) 7(15.9%)
Age (year) 47.4 ± 7.1 45.67 ± 7.8 46.63 ± 8.1 48.69 ± 6.4
NT-proBNP (pg/mL) 210 (5-1980) 112 (5-180) 130 (11,7-860) 315 (86-1980)
Anemia 43 (59%) 3 (33%) 8 (42.1%) 32 (72.7%)
Drugs
Diuretics 32 (44.4%) 0 (0%) 9 (47.4%) 23 (52.3%)
Beta blockers 35 (48.6%) 0 (0%) 11 (57.9%) 24 (54.5%)
NT-proBNP: N terminal-pro brain natriuretic peptide; CTP: child turcotte pugh
Table 2. Correlation between degree of liver cirrhosis and NT-proBNP 
Variable Total CTP A CTP B CTP C r p
NT-proBNP 
(pg/mL)
210
(5-1980)
112  
(5-180)
130  
(11,7-860)
315  
(86-1980) 0,686 0,000
NT-proBNP: N terminal-pro brain natriuretic peptide; CTP: child turcotte pugh
There was also a significant comparison between 
NT-proBNP and CTP A,B, and C (p = 0,000) Table 3 
shows the comparison of NT-proBNP level between 
each group of CTP. In this trial there was significant 
comparison between the group of CTP A and C, CTP 
B and C (p < 0.05). Kruskall-Wallis test was performed 
to analyze the NT-proBNP level between CTP A, B, 
and C. To find out the between each group of CTP 
we used post hoc Mann-Whitney test. Multivariate 
analysis of the cofounding variables such as age, sex, 
anemia, diuretics, and beta blockers showed there 
were no significant relation between NT-proBNP and 
those variables (Table 4). Multivariate analysis using 
Chi-square comparison test.
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Table 3. The comparison of NT-proBNP level between each 
CTP groups
Group p
CTP A and CTP B 0,182
CTP A and CTP C 0,000
CTP B and CTP C 0,000
CTP: child turcotte pugh
Table 4. Multivariate variables that were influenced NT-proBNP 
level
Variable p
Age 0,96
Sex 0,28
Anemia 0,19
Diuretics 0,41
Beta Blockers 0,48
DISCUSSION
Incidence for LC was still high. In our study, 
there were 72 patients with LC, 79.2% were male, 
the youngest age was 30 years and the oldest was 
60 years, mean of age was 47.40 ± 7.1 years. Based 
on the degree, CTP C was the most of all (61.1%). 
Results from our study was similar to studies from 
Indrawan et al that stated that 72.7% of 72 LC patients 
at Sanglah Hospital in 2014 were male.10 Suwindnya 
et al also stated that among LC subjects, the youngest 
age was 25,4 years and the oldest was 69.10 years, 
with mean age was 50,86 ± 9,84 years.11 LC are often 
assymptomatic at early state due to parenchymal 
compensation providing normal liver function, causing 
a delayed arrival at health care provider. As the disease 
progressing, compensation is no longer adequate and 
liver failure along with portal hypertension emerged.
LC complications occur along with the severity of 
the liver disorder. Cirrhotic cardiomyopathy is one of 
the complication, which based on gastroenterology 
world congress in Montreal in 2005 is diagnosed by 
more than one finding: diastolic dysfunction (DD) 
or systolic dysfunction (SD) on LC, hearth chamber 
structure changing (enlargement of the atrium), 
electrophysiological disorder (prolongation of QT 
interval), and elevation of natriuretic peptide such as 
NT-proBNP.12 In this study, we searched for correlation 
of NT-proBNP and the severity of LC. Median of NT-
proBNP values on CTP A : B : C were 112 (5-180) pg/
mL : 130 (11.7-860) pg/mL : 315 (86-1980) pg/mL. 
NT-proBNP elevated along with the severity of liver 
damage with the highest median of NT-proBNP was 
in the CTP C group. The results were consistent with 
Eldeeb et al who found a significant elevation of NT-
proBNP on CTP C which correlated to enlargement 
of left atrium, and Papasterigiou et al got NT-proBNP 
elevation was more in CTP C subjects which associated 
with more DD incidence on CTP C.4,6
We found a strong positive correlation between 
severity of LC and NT-proBNP (r = 0.686; p = 0.000). 
Liver parenchymal damage caused blunted of beta 
receptors responses on the heart muscles, increasing of 
endocanabinoids, nitric oxide (NO), carbon monoxide 
(CO), and the myocardial wall stiffness that led to 
systolic, diastolic, and electrophysiological disorder 
in LC.13 CTP score reflects the severity of liver 
parenchymal damage, so the more severe the LC caused 
more severe heart disorder in LC. NT-proBNP elevated 
in heart disorders such as congestive heart failure and 
other conditions like cirrhotic cardiomyopathy.
LC severity correlated with LC related-heart 
disorder, and the heart disorder correlated with NT-
proBNP elevation. On LC, there are systolic and 
diastolic dysfunctions that causes volume and pressure 
overload, that increases NT-proBNP secretion. Diastolic 
dysfunction appears on the early stage of cirrhotic 
cardiomyopathy, followed by systolic dysfunction on 
the late stage that gives the heart failure symptoms.14 
Some studies supported our results are Ziada et al and 
Eldeeb et al with moderate correlation (r = 0.485; p = 
0.019; and r = 0.4; p = 0.0001) and Henriksen et al with 
strong correlation (r = 0.89; p < 0.001).6,7,15 
Based on LC severity, in our study there was a 
significant difference for NT-proBNP in CTP A, B, 
and C. We also conducted post hoc analysis to find the 
difference of NT-proBNP values in each CTP groups, 
we found significant differences between CTA A and 
C groups, and between CTP B and C (p < 0.05). At the 
early stage of LC, heart disorder occured as diastolic 
dysfunction that could elevated NT-proBNP, that may 
caused no NT-proBNP value differences between CTP 
A dan B in our study. NT-proBNP elevated more in 
CTP C due to more severe the heart disorder occured 
in CTP C.13,14 It explained our results where there were 
significant differences of NT-proBNP between CTP A 
and C, and between CTP B and C.
 We analyzed some cofounding variables, which 
were anemia, beta blockers, and diuretics usage, 
and there were no significant correlations between 
those variables and NT-proBNP elevations. NT-
proBNP was not affected by anemia, beta blockers 
and diuretics usage in this study. On severe LC with 
severe complications, diuretics and beta blockers were 
required and so in our study, incident of anemia, beta 
blockers, and diuretics usage were more in CTP C.
CONCLUSION
There was strong positive correlation between 
degree of LC and NT-proBNP.
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